Liver International: Vol 45, No 4

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Liver International

Journal list menu

Tools

Follow journal

Liver International: Volume 45, Issue 4

Download PDFs

ISSUE INFORMATION

Issue Information

LETTER TO THE EDITOR

In Response to the Letter to the Editor by Walia et al. RE: Kassa et al. 2024 ‘Prevalence, Trends, and Distribution of Hepatitis C Virus Among the General Population in Sub-Saharan Africa: A Systematic Review and Meta-Analysis’

Comment: Prevalence, Trends and Distribution of HCV Among the General Population in Sub-Saharan Africa: An SLR-MA

Enhancing the Understanding of Obesity and Liver Health: Addressing Lifestyle, Socio-economic and Ethnic Disparities

MASLD, At-Risk MASH and Increased Liver Stiffness Are Associated With Young Adulthood Obesity Without Residual Risk After Losing Obesity

Precision in Diagnosis of Liver Fibrosis in MASLD: Machine Learning-Based Scores May Be More Accurate Than Conventional NITs

Precision in Liver Diagnosis: Varied Accuracy Across Subgroups and the Need for Variable Thresholds in Diagnosis of MASLD

Response to: Precision in Diagnosis of Liver Fibrosis in MASLD: Machine Learning Based Scores May Be More Accurate Than Conventional NITs

REVIEW

Representation of Sex, Race and Ethnicity in MASH Randomised Controlled Trials: A Systematic Review and Meta-Analysis

Bridging Gaps in Demographic Equity: Towards Inclusive Representation in MASH Randomised Trials

ORIGINAL ARTICLE

TMEM115 as an Oncogenic and Immunological Biomarker in Hepatocellular Carcinoma

MINI REVIEW

PNPLA3 I148M and Hepatocellular Carcinoma

LETTER TO THE EDITOR

Real-World Case Supporting Drug-Induced Autoimmune Hepatitis: Updated Insights and Analysis of the FAERS Data

Response to the Letter to the Editor: Real-World Case Supporting Drug-Induced Autoimmune Hepatitis

ORIGINAL ARTICLE

Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study

Evaluating the Macroeconomic Burden of Hepatitis B and the Gains From Timely Coverage Investments in China

DRD2-Mediated AMPK Ubiquitination Regulates the Occurrence of Hepatic Steatosis

Refining the DRD2-MKRN1-AMPK Axis: Priorities for Mechanistic Validation in Hepatic Steatosis Pathogenesis

MASLD, At-Risk MASH and Increased Liver Stiffness Are Associated With Young Adulthood Obesity Without Residual Risk After Losing Obesity

Enhancing the Understanding of Obesity and Liver Health: Addressing Lifestyle, Socio-economic and Ethnic Disparities

MASLD And MASH Risk: Does Losing Obesity Reverse the Metabolic Footprint?

Safety of Anticoagulation When Undergoing Endoscopic Variceal Ligation: A Systematic Review and Meta-Analysis

A Commentary on ‘Safety of Anticoagulation When Undergoing Endoscopic Variceal Ligation: A Systematic Review and Meta-Analysis’

LETTER TO THE EDITOR

Enhancing MASLD Screening: Long-Term Management and Accuracy Challenges

Pharmaco-Economic Assessment of Screening Strategies for High-Risk MASLD in Primary Care

ORIGINAL ARTICLE

Exploring the potential of large language models in identifying metabolic dysfunction-associated steatotic liver disease: A comparative study of non-invasive tests and artificial intelligence-generated responses

Inhibition of MALT1 Protease Attenuates Hepatic Sinusoidal Obstruction Syndrome by Modulating NRF2/HO1 and NF-κB Pathway

Disentangling Organ-Specific Roles of Farnesoid X Receptor in Bile Acid and Glucolipid Metabolism

REVIEW

Function of PNPLA3 I148M—Lessons From In Vivo Studies in Humans

ORIGINAL ARTICLE

Association between MASLD and increased risk of serious bacterial infections requiring hospital admission: A meta-analysis

LETTERS TO THE EDITOR

The liver-specific diagnosis and prognosis of fibrotic NASH through modulating fibroblast growth factor 21

ORIGINAL ARTICLE

Genetic Evidence for GLP-1 and GIP Receptors as Targets for Treatment and Prevention of MASLD/MASH

REVIEW

Epidemiology and Risk Determinants of Drug-Induced Liver Injury: Current Knowledge and Future Research Needs

ORIGINAL ARTICLE

Exploring the Relationship Between NOD2 Risk Variants and First Decompensation Events in Cirrhotic Patients With Varices

REVIEW

New Scenarios in Liver Transplantation for Hepatocellular Carcinoma

ORIGINAL ARTICLE

Metabolic Dysfunction-Associated Steatotic Liver Disease Increases the Risk of Severe Infection: A Population-Based Cohort Study

LETTER TO THE EDITOR

The Relationship Between Ferroptosis and Metabolic Dysfunction-Associated Fatty Liver Disease

ORIGINAL ARTICLE

Incidence and Predictors of HBsAg Loss in Paediatric Patients With Chronic Hepatitis B Undergoing Antiviral Treatment

Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH

Elevated Porcupine Disrupts Lipid Metabolism and Promotes Inflammatory Response in MASLD

REVIEW

Accuracy of Non-Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review

BRIEF REPORT

Association of Liver Disease and Chronic Pruritus: A Case–Control Study

ORIGINAL ARTICLE

Spatial and Single-Cell Transcriptomics Reveals the Regional Division of the Spatial Structure of MASH Fibrosis

Clinical Utility of Genetic Variants in PNPLA3 and TM6SF2 to Predict Liver-Related Events in Metabolic Dysfunction-Associated Steatotic Liver Disease

LETTER TO THE EDITOR

Impact of Direct-Acting Antiviral Therapy on All-Cause Mortality in Chronic Hepatitis C Patients

ORIGINAL ARTICLE

Global Trends and Inequalities of Liver Complications Related to Metabolic Dysfunction-Associated Steatotic Liver Disease: An Analysis From 1990 to 2021

Non-Linear Trends in the Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) From 1990 to 2021

Pharmaco-Economic Assessment of Screening Strategies for High-Risk MASLD in Primary Care

Enhancing MASLD Screening: Long-Term Management and Accuracy Challenges

REVIEW

¹⁶⁶Ho-RadioEmbolizaTiOn Using personalized prediCtive dosimetry in patients with Hepatocellular carcinoma: A prospective, single-centre study (RETOUCH)